Paul Meister

Paul Meister is a partner at Novalis LifeSciences and co-founder of Liberty Lane Partners, a private investment company. He serves as Chairman of Arbor Biotechnologies and Amneal Pharmaceuticals, and is on the board of Ori Biotech, Mercy BioAnalytics and several other early-stage life science and diagnostic companies.

Paul previously served as Chairman of Thermo Fisher Scientific and Vice Chairman of Fisher Scientific International. He also served as Chairman and CEO of inVentiv Health (now Syneos Heath.)

Paul earned a MBA from Northwestern University and a B.A. from the University of Michigan, and serves on the board of Michigan’s Life Sciences Institute.